CN104586962A - 一种生肌长皮烧伤药膏及其制备方法 - Google Patents
一种生肌长皮烧伤药膏及其制备方法 Download PDFInfo
- Publication number
- CN104586962A CN104586962A CN201510029293.0A CN201510029293A CN104586962A CN 104586962 A CN104586962 A CN 104586962A CN 201510029293 A CN201510029293 A CN 201510029293A CN 104586962 A CN104586962 A CN 104586962A
- Authority
- CN
- China
- Prior art keywords
- ointment
- parts
- radix
- vitamin
- treating burn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Pregnancy & Childbirth (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Animal Husbandry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
Abstract
本发明公开了一种生肌长皮烧伤药膏及其制备方法,该药膏其包括如下重量份的组分:头孢菌素5-15份,庆大霉素5-15份、人参5-20份、蜂胶10-20份、紫草5-20份、黄芩10-20份、蒙脱石10-20份、大黄6-20份、人胎盘组织液10-20份、冰片0.5-5份、维生素B6 5-15份、维生素C 8-15份、软膏基质200份。本发明能够快速修复局部被损组织,加速创面的愈合,明显缩短了Ⅲ度烧伤的愈合天数。
Description
技术领域
本发明涉及一种生肌长皮烧伤药膏及其制备方法。
技术背景
烧伤是一种危害人类健康和容貌的常见病。烧伤本身造成的皮肤损伤或者治疗过程中导致的新的皮肤损伤,很容易造成色素沉着、疤痕残留等容貌问题,最后多需植皮整容,不仅加重病人痛苦,且费用昂贵。
烧伤后次日,由于病人烧伤部位会出现水泡式皮损,重度肿胀,按照传统疗法,需撕皮包扎,肿胀加重需手术切开减胀,这会加重病人痛苦,给病人火上浇油。
国内外传统治疗烧伤是在进行一般的创面清洁处理后,然后剪掉视为腐皮及坏死组织的水泡组织,包扎保护、分期切痂植皮等保守疗法,并辅以静脉注射抗生素。数次切痂植皮,病人痛苦异常,并且费用昂贵,最后多需整形美容,治疗期延长,容易造成伤口感染。目前通用的暴露疗法在抑制大量细菌繁殖的同时,也导致人体正常细胞的分裂增生受阻,因而不利于烧伤创面的修复和再生,容易造成疤痕残留,病程变长,需过“三关”,死里逃生。
专利号为ZL95118978.6的中国专利是本发明人的早期研究成果,其公开了一种消炎止痛烧伤药膏,采用抗生素和中药中西结合,抗感染作用强,镇痛效果好,可缩短创面愈期,能有效降低疤痕发生率。其对于深Ⅱ度创面愈合天数一般为4-13天,较使用“美宝”湿润烧伤膏药的对照组愈合天数明显缩短,但其对于Ⅲ度烧伤的愈合天数仍较长,为21-30天。
发明内容
针对以上技术问题,本发明的目的是提供一种能有效缩短Ⅲ度烧伤愈合天数、无瘢痕残留且有效减轻病人痛苦的生肌长皮烧伤药膏,并提供其制备方法,该药膏能解决“Ⅱ度烧伤不留疤,Ⅲ度烧伤不植皮”的世界难题,用涂药生肌长皮代替手术植皮。
为实现以上目的,本发明采用如下技术方案:
一种生肌长皮烧伤药膏,其包括如下重量份的组分:头孢菌素5-15份,庆大霉素5-15份、人参5-20份、蜂胶10-20份、紫草 5-20份、黄芩10-20份、蒙脱石10-20份、大黄6-20份、人胎盘组织液10-20份、冰片0.5-5份、维生素B6 5-15份、维生素C 8-15份、软膏基质200份。
优选地,所述头孢菌素为头孢哌酮钠。对特殊病人,可根据其细菌培养药敏实验结果选用其它抗生素。
优选地,所述软膏基质为凡士林或W/O型基质。
人胎盘组织液选用市售产品均可,如邯郸康业制药有限公司生产的批准文号为“国药准字S13020002”的人胎盘组织液。
本发明还提供了所述生肌长皮烧伤药膏的制备方法,其步骤如下:
(1)按所述重量份称取人参、蜂胶、紫草、黄芩和大黄,用75%酒精浸润18-24小时,晾干后,放入干燥箱内,在30-40℃温度下烘干,粉碎,过120目筛,待用;
(2)按所述重量份称取蒙脱石,研磨,过120目筛,加入所述冰片,研磨,待用;
(3)按所述重量份称取头孢菌素、庆大霉素、维生素B6和维生素C,混匀后加入步骤(1)和(2)所得混合物,混匀,最后加入人胎盘组织液和熔溶后的软膏基质,研匀即可。
本发明药膏在治疗时,采用暴露疗法,对烧伤创面进行一般的清洁处理后,将有水泡处穿泡放水,不撕掉传统疗法中误认为的腐皮及坏死组织,将该烧伤药膏均匀地涂在创面上,次日,在原创面上再补涂该药膏(原药膏不必清除),如此反复涂抹,直至结药痂,待到痂脱伤愈,恢复原貌。
本发明通过各药物组分的合理配伍,在有效杀灭被损皮肤组织中残留或繁殖的细菌、消除急性感染病因的同时,还具有良好的生肌长皮作用,药物透皮吸收度强,明显减少创面渗出液,能够快速修复局部被损组织,加速创面的愈合,明显缩短了Ⅲ度烧伤的愈合天数,并有效地避免了肉芽组织的再生,抑制了大纤维母细胞生长,防止了疤痕的形成。此外本发明药膏还具有良好的镇痛效果,大大减轻了烧伤引起的疼痛给患者带来的痛苦,同时也有效地避免了烧伤疼痛给病人带来的生理、病理方面的负效应。
本发明药物所产生的积极效果从下述临床验证资料中得以证实。
一、烧伤病例的选择:
符合黄家驷所著《外科学》Ⅲ度烧伤者,按双盲随机法分为两组,实验组使用本发明药物,对照组使用“美宝”湿润烧伤膏。
二、疗效评定标准
1、创面感染的评定标准
按Pruitt(1979)所述创面感染
2、创面愈合的评定标准
按黄家驷所著《外科学》所定标准
3、瘢痕愈合评定标准
按黄家驷所著《外科学》所定标准
4、创面疼痛的评定标准
以15分钟后仍感到疼痛难耐,病人要求使用镇痛药为阳性统计对象。
三、临床观察结果
表1 创面感染发生率对比情况
组 别 | 总例数 | 感染数 | 感染率 | P |
实验组 | 180 | 0 | 0 | |
对照组 | 120 | 3 | 2.50% | <0.01 |
表2 烧伤瘢痕发生率对比情况
组 别 | 总例数 | 疤痕数 | 疤痕率 | P |
实验组 | 240 | 0 | 0 | |
对照组 | 240 | 128 | 53 | <0.05 |
表3 创面植皮率对比情况
组 别 | 总例数 | 植皮数 | 植皮率 | P |
实验组 | 180 | 0 | 0 | |
对照组 | 120 | 2 | 1.57% | <0.05 |
表4 创面疼痛发生率对比情况
组 别 | 总例数 | 疼痛数 | 疼痛率 | P |
实验组 | 180 | 0 | 0 | |
对照组 | 120 | 38 | 31.6 | <0.01 |
本发明与专利号为ZL95118978.6的中国专利对于Ⅲ度烧伤创面愈合天数的比较见表5(其中实验组为使用本发明药膏,对照组为使用ZL95118978.6的药膏)。
表5 Ⅲ度创面愈合天数对比情况
。
典型病例
1、张安生,男,38岁,山东省曹县桃园乡闫村人。
2014年11月26日下午15:30
主诉:面部烫伤半天
缘于当日11点,在家做饭时,高压锅爆炸,烫伤面部,当即到河北医大一院烧伤科喷药水、疼痛难忍、慕名求医。
查:面部潮红、存在水泡、Ⅲ度烫伤,坐立不宁,涂本发明药膏后片刻鼾声入睡。
处理:常规消毒、外涂本发明烧伤药膏,第5天患者洗光,面如常人。
2、谭剑,男,28岁,中国人民解放军军械工程学院保卫处,现役军人。
2007年5月25日
主诉面部烧伤6天
缘于6天前燃放火药烧伤面部及左上臂,当时被送解放军和平医院烧伤科住院,面貌全非,全面部焦痂,面肿如斗,为Ⅲ度烧伤,第六天烧伤科主任准备植皮,告知本人准备毁容破相,故慕求名医。经涂本发明药膏后,未植皮,10天治愈,面部无疤痕,色素无沉着,面如常人。
3、张日升,男,58岁。2014年12月1日在维修煤气管道时不慎失火,将面、颈部及双手深Ⅲ度烧伤,立即外涂湿润伤灵膏,次日面部及双手重度肿胀,面部皮肤大部脱落,疼痛难忍。外涂本发明药膏,未输液,未住院,六天治愈,未留疤痕,面貌如常。
具体实施方式
实施例1:
本实施例包括如下重量的组分:头孢哌酮钠15千克、庆大霉素15千克、维生素C 15千克、维生素B6 15千克、人参20千克、黄芩20千克、蜂胶20千克、紫草20千克、大黄6千克、蒙脱石20千克、人胎盘组织液10千克、冰片5千克、软膏基质200千克。
本实施例的制备方法为:
(1)按所述重量份称取人参、蜂胶、紫草、黄芩和大黄,用75%酒精浸润18-24小时,晾干后,放入干燥箱内,在30-40℃温度下烘干,粉碎,过120目筛,待用;
(2)按所述重量份称取蒙脱石,研磨,过120目筛,加入所述冰片,研磨,待用;
(3)按所述重量份称取头孢菌素、庆大霉素、维生素B6和维生素C,混匀后加入步骤(1)和(2)所得混合物,混匀,最后加入人胎盘组织液和熔溶后的软膏基质,研匀即可。
将蒙脱石研磨粉碎,过120目筛后,加入冰片,研均,待用;
将头孢哌酮、庆大霉素、复合维生素C,细粉混合后加入中草药粉、冰片粉混匀,最后加入熔溶后的麻油,充匀研匀。
以下6个实施例药膏的制备方法同实施例1相同,只是药物组分配比有所不同,但疗效基本相同。
。
Claims (4)
1.一种生肌长皮烧伤药膏,其特征在于:其包括如下重量份的组分:头孢菌素5-15份,庆大霉素5-15份、人参5-20份、蜂胶10-20份、紫草 5-20份、黄芩10-20份、蒙脱石10-20份、大黄6-20份、人胎盘组织液10-20份、冰片0.5-5份、维生素B6 5-15份、维生素C 8-15份、软膏基质200份。
2.根据权利要求1所述的一种生肌长皮烧伤药膏,其特征在于:所述头孢菌素为头孢哌酮钠。
3.根据权利要求1所述的一种生肌长皮烧伤药膏,其特征在于:所述软膏基质为凡士林或W/O型基质。
4.权利要求1-3任一项所述的生肌长皮烧伤药膏的制备方法,其特征在于步骤如下:
(1)按所述重量份称取人参、蜂胶、紫草、黄芩和大黄,用75%酒精浸润18-24小时,晾干后,放入干燥箱内,在30-40℃温度下烘干,粉碎,过120目筛,待用;
(2)按所述重量份称取蒙脱石,研磨,过120目筛,加入所述冰片,研磨,待用;
(3)按所述重量份称取头孢菌素、庆大霉素、维生素B6和维生素C,混匀后加入步骤(1)和(2)所得混合物,混匀,最后加入人胎盘组织液和熔溶后的软膏基质,研匀即可。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510029293.0A CN104586962B (zh) | 2015-01-21 | 2015-01-21 | 一种生肌长皮烧伤药膏及其制备方法 |
US15/542,420 US20180021343A1 (en) | 2015-01-21 | 2015-03-16 | Burn ointment for promoting tissue regeneration and skin growth, and preparation method therefor |
PCT/CN2015/074275 WO2016115768A1 (zh) | 2015-01-21 | 2015-03-16 | 一种生肌长皮烧伤药膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510029293.0A CN104586962B (zh) | 2015-01-21 | 2015-01-21 | 一种生肌长皮烧伤药膏及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104586962A true CN104586962A (zh) | 2015-05-06 |
CN104586962B CN104586962B (zh) | 2016-01-27 |
Family
ID=53113233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510029293.0A Active CN104586962B (zh) | 2015-01-21 | 2015-01-21 | 一种生肌长皮烧伤药膏及其制备方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20180021343A1 (zh) |
CN (1) | CN104586962B (zh) |
WO (1) | WO2016115768A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758310A (zh) * | 2015-04-01 | 2015-07-08 | 山东司邦得制药有限公司 | 复方蒙脱石蔗糖软膏及其制备方法和应用 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110917331A (zh) * | 2019-11-13 | 2020-03-27 | 安徽科门生物科技有限公司 | 一种促进手术后伤口愈合的重要组合物及制备工艺 |
CN112755056A (zh) * | 2021-02-02 | 2021-05-07 | 楚东开 | 一种烫伤药及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1058719A (zh) * | 1990-08-04 | 1992-02-19 | 中国石油化工总公司兰州炼油化工总厂 | 伤口快速愈合生肌散的配制方法 |
CN101284109A (zh) * | 2007-04-09 | 2008-10-15 | 王兴礼 | 一种治疗烧、烫、冻伤真皮再生的药物 |
CN101401852A (zh) * | 2008-09-12 | 2009-04-08 | 钟祥市春林医院 | 一种治疗烧烫伤的中西结合外敷制剂 |
CN101869655A (zh) * | 2010-07-08 | 2010-10-27 | 刘福民 | 速效无疤痕烧伤烫伤膏 |
CN103585347A (zh) * | 2013-10-30 | 2014-02-19 | 杨光英 | 一种治疗烧烫伤的中药组合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1058619C (zh) * | 1995-12-06 | 2000-11-22 | 张金安 | 一种消炎止痛烧伤药膏 |
CN102988246A (zh) * | 2012-08-13 | 2013-03-27 | 齐贵娥 | 蜂王浆羊胎盘美容护肤霜 |
-
2015
- 2015-01-21 CN CN201510029293.0A patent/CN104586962B/zh active Active
- 2015-03-16 WO PCT/CN2015/074275 patent/WO2016115768A1/zh active Application Filing
- 2015-03-16 US US15/542,420 patent/US20180021343A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1058719A (zh) * | 1990-08-04 | 1992-02-19 | 中国石油化工总公司兰州炼油化工总厂 | 伤口快速愈合生肌散的配制方法 |
CN101284109A (zh) * | 2007-04-09 | 2008-10-15 | 王兴礼 | 一种治疗烧、烫、冻伤真皮再生的药物 |
CN101401852A (zh) * | 2008-09-12 | 2009-04-08 | 钟祥市春林医院 | 一种治疗烧烫伤的中西结合外敷制剂 |
CN101869655A (zh) * | 2010-07-08 | 2010-10-27 | 刘福民 | 速效无疤痕烧伤烫伤膏 |
CN103585347A (zh) * | 2013-10-30 | 2014-02-19 | 杨光英 | 一种治疗烧烫伤的中药组合物及其制备方法 |
Non-Patent Citations (3)
Title |
---|
张华等: "外用药物及材料治疗烧烫伤研究进展", 《实用药物与临床》 * |
王丛斌等: "虎杖烧伤油治疗烧伤体会", 《光明中医》 * |
金山: "蒙脱石对细菌的吸附作用", 《精细化工原料及中间体》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758310A (zh) * | 2015-04-01 | 2015-07-08 | 山东司邦得制药有限公司 | 复方蒙脱石蔗糖软膏及其制备方法和应用 |
CN104758310B (zh) * | 2015-04-01 | 2018-10-12 | 山东司邦得制药有限公司 | 复方蒙脱石蔗糖软膏及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104586962B (zh) | 2016-01-27 |
US20180021343A1 (en) | 2018-01-25 |
WO2016115768A1 (zh) | 2016-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103705613A (zh) | 一种治疗烧烫伤的外用药 | |
CN104586962B (zh) | 一种生肌长皮烧伤药膏及其制备方法 | |
CN101919927B (zh) | 一种治疗烫伤的喷雾剂 | |
CN104337984A (zh) | 治疗肘关节骨化性肌炎的外用中药膏剂 | |
CN104306674A (zh) | 一种治疗烧伤、烫伤的药膏 | |
CN103845578A (zh) | 治疗烧烫伤、褥疮、带状疱疹外用酊剂及制备方法 | |
CN101066307B (zh) | 无疤痕烧伤药粉及其制备方法 | |
CN104208295A (zh) | 一种烫伤药 | |
CN103142727B (zh) | 治疗人体烧烫伤的中草药组合物 | |
CN104491462B (zh) | 一种治疗烫伤的药物组合物 | |
CN101357153B (zh) | 无疤烧烫伤药及其制备方法 | |
CN108283670A (zh) | 一种治疗烧烫伤的药物组合物及其制备方法 | |
CN103127274A (zh) | 一种四季火烧烫伤药 | |
CN102526438B (zh) | 一种治疗烧伤烫伤的药物及其制备方法 | |
CN101983712A (zh) | 冠心病的新型治疗药物 | |
CN105031426A (zh) | 一种治疗烧烫伤的外用药酒 | |
CN105582243A (zh) | 一种治疗日晒疮的中药组合物 | |
CN105030928A (zh) | 一种治疗丛集性头痛的中药及其制备方法 | |
CN104547634A (zh) | 一种中药组合物在制备治疗褥疮药物中的用途 | |
CN101987191B (zh) | 一种治疗烧烫伤的中药组合物 | |
CN103977364A (zh) | 一种治疗烧烫伤的中药制剂 | |
CN103816358A (zh) | 一种用于清肺化痰的中药组合物 | |
CN103860642A (zh) | 一种治疗发烧的药物及其制备方法 | |
CN102824418A (zh) | 一种治疗烧伤和烫伤的中药粉剂 | |
CN108836991A (zh) | 一种治疗烧烫晒伤的中药膏油纱布及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |